Clinical trialNCT00280917CompletedPhase 2Interventional

Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients

SponsorCan-Fite BioPharmaEnrollment254Rheumatoid Arthritis

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Michael H Silverman, MD
BioStrategics Consulting Ltd
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Bulgaria

Can-Fite Investigational Site
Plovdiv, Bulgaria
Can-Fite Investigational Site
Sofia, Bulgaria
Can-Fite Investigational Site
Sofia, Bulgaria
Can-Fite Investigational Site
Stara Zagora, Bulgaria

Israel

Can-Fite Investigational Sites
Afula, Israel
Can-Fite Investigational Site
Ashkelon, Israel
Can-Fite Investigational Site
Beer Yaakov, Israel
Can-Fite Investigational Site
Haifa, Israel
Can-Fite Investigational Site
Haifa, Israel
Can-Fite Investigational Site
Jerusalem, Israel
Can-Fite Investigational Site
Jerusalem, Israel
Can-Fite Investigational Site
Jerusalem, Israel
Can-Fite Investigational Site
Kfar Saba, Israel
Can-Fite Investigational Site
Tel Litwinsky, Israel

Poland

Can-Fite Investigational Site
Bialystok, Poland
Can-Fite Investigational Site
Lublin, Poland
Can-Fite Investigational Site
Sopot, Poland
Can-Fite Investigational Site
Szczecin, Poland

Romania

Can-Fite Investigational Site
Brasov, Romania
Can-Fite Investigational Site
Bucharest, Romania
Can-Fite Investigational Site
Bucharest, Romania
Can-Fite Investigational Site
Cluj-Napoca, Romania
Can-Fite Investigational Site
Iași, Romania

Serbia

Can-Fite Investigational Site
Belgrade, Serbia
Can-Fite Investigational Site
Niška Banja, Serbia
Can-Fite Investigational Site
Zemun, Serbia

Ukraine

Can-Fite Investigational Site
Kiev, Ukraine
Can-Fite Investigational Site
Kiev, Ukraine
Can-Fite Investigational Site
Kiev, Ukraine
Can-Fite Investigational Site
Kiev, Ukraine

United States

Can-Fite Investigational Site
Peoria, Arizona, United States
Can-Fite Investigational Site
Albany, New York, United States
Can-Fite Invesitigational Site
Cleveland, Ohio, United States
Can-Fite Investigational Site
Perrysburg, Ohio, United States
Can-Fite Investigational Site
Sugar Land, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jun 2006
Primary completion: 30 Apr 2007
Completion: 30 Apr 2007
Last update posted: 18 Sept 2023
Registered enrollment: 254
Registry id: NCT00280917

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.